Expert Interview
Examining the results of the Phase 3 ATTRibute-CM study of acoramidis in ATTR-CM by BridgeBio Pharma presented at International Symposium of Amyloidosis (ISA)
Ticker(s): BBIOInstitution: Hospital Clinico San Carlos
- Cardiology Consultant in the field of Cardiac Imaging, specifically oriented to Cardiac CT, Cardiac MR and Echocardiography guidance of structural heart disease procedures.
- Treats 20 patients with attr-cm
- Author of more than 50 articles in international journals and several chapters in cardiology books and has presented over 100 communications in national and international congresses.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
